| [1] |
石炳毅, 肖漓.肾移植排斥反应的无创诊断进展及展望[J].中华器官移植杂志, 2015, 36(9): 513-514. DOI:10. 3760/cma.j.issn.0254-1785. 2015.09.001.
Shi BY, Xiao L. Progress and prospect of noninvasive diagnosis of renal allograft rejection[J]. Chin J Organ Transplant, 2015, 36(9): 513-514. DOI: 10. 3760/cma.j.issn.0254-1785.2015.09.001.
|
| [2] |
Lefaucheur C, Loupy A, Hill GS, et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation[J]. J Am Soc Nephrol, 2010, 21(8):1398-1406. DOI:10.1681/ASN. 2009101065.
|
| [3] |
Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure[J]. Am J Transplant, 2009, 9(11):2520-2531. DOI: 10.1111/j.1600-6143.2009.02799.x.
|
| [4] |
Inui M, Miyazato T, Furusawa M, et al. Successful kidney transplantation after stepwise desensitization using rituximab and bortezomib in a highly HLA-sensitized and ABO incompatible high titer patient[J]. Transplant Direct, 2016, 2(8): e92. DOI: 10.1097/TXD.0000000000000603.
|
| [5] |
韩永, 蔡明, 郭晖, 等.移植肾术后急性抗体介导性排斥反应的诊断与治疗[J].中华实用诊断与治疗杂志, 2015, 29(1): 34-36. DOI: 10.13507/j.issn.1674-3474.2015.01.012.
Han Y, Cai M, Guo H, et al. Diagnosis and treatment of acute antibody mediated rejection after renal transplantation[J]. J Chin Pract Diagn Ther, 2015, 29(1): 34-36. DOI: 10.13507/j.issn.1674-3474.2015.01.012.
|
| [6] |
徐秀红, 贾保祥.供者特异性抗体对肾移植术后患者急性排斥和肾功能的影响研究[J].临床和实验医学杂志, 2014, 13(2): 92-95. DOI: 10.3969/j.issn.1671-4695.2014.02.005.
Xu XH, Jia BX. Influence of donor-specific antibodies on acute renal transplant rejection and renal function in patients with renal transplant[J]. J Clin Exp Med, 2014, 13(2): 92-95. DOI: 10.3969/j.issn.1671-4695.2014.02.005.
|
| [7] |
Loupy A, Lefaucheur C, Vernerey D, et al. Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection[J]. J Am Soc Nephrol, 2014, 25 (10):2267-2277. DOI: 10.1681/ASN.2013111149.
|
| [8] |
Hirai T, Furusawa M, Omoto K, et al. Analysis of predictive and preventive factors for de novo DSA in kidney transplant recipients[J]. Transplantation, 2014, 98(4):443-450. DOI: 10.1097/TP.0000000000000071.
|
| [9] |
Everly MJ, Rebellato LM, Haisch CE, et al. Incidence and impact of de novo donor-specific alloantibody in primary renal allografts[J]. Transplantation, 2013, 95(3):410-417. DOI:10.1097/TP.0b013e 31827d62e3.
|
| [10] |
Wiebe C, Pochinco D, Blydt-Hansen TD, et al. ClassⅡ HLA epitope matching-a strategy to minimizede novodonor-specific antibody development and improve outcomes[J]. Am J Transplant, 2013, 13(12):3114-3122. DOI: 10.1111/ajt.12478.
|
| [11] |
李凯群, 苗芸.肾移植和供体特异性抗体[J].器官移植, 2016, 7(5):394-398. DOI: 10.3969/j.issn.1674-7445.2016.05.013.
Li KQ, Miao Y. Renal transplantation and donor specific antibodies[J]. Organ Transplant, 2016, 7(5): 394-398.DOI: 10.3969/j.issn.1674-7445.2016.05.013.
|
| [12] |
Böhmig GA, Kikic Z, Wahrmann M, et al. Detection of alloantibody-mediated complement activation: a diagnostic advance in monitoring kidney transplant rejection?[J]. Clin Biochem, 2016, 49(4/5):394-403. DOI: 10.1016/j.clinbiochem.2015.05.024.
|
| [13] |
肖漓, 白剑, 何秀云, 等.巨细胞病毒感染的肾移植受者中性粒细胞表面黏附分子的表达及意义[J].中华医学杂志, 2016, 96(20):1562-1565. DOI: 10.3760/cma.j.issn.0376-2491.2016.20.003.
Xiao L, Bai J, He XY, et al. Expression and significance of neutrophil surface adhesion molecules in renal transplant recipients with cytomegalovirus infection[J]. Natl Med J China, 2016, 96(20):1562-1565. DOI: 10.3760/cma.j.issn.0376-2491.2016.20.003.
|
| [14] |
Rostaing LP, Malvezzi P. HLA-incompatible kidney transplantation--worth the risk?[J]. N Engl J Med, 2016, 374(10):982-984. DOI: 10.1056/NEJMe1601379.
|
| [15] |
Kloprogge F, Piola P, Dhorda M, et al. Population pharmacokinetics of lumefantrine in pregnant and nonpregnant women with uncomplicated plasmodium falciparum malaria in Uganda[J]. CPT Pharmacometrics Syst Pharmacol, 2013, 2:e83. DOI: 10.1038/psp.2013.59.
|
| [16] |
许亮, 蔡明, 李州利, 等.小剂量静脉滴注人免疫球蛋白在群体反应抗体阳性肾移植患者中的临床应用分析[J].中国现代医学杂志, 2016, 26(13): 89-91. DOI: 10.3969/j.issn.1005-8982.2016.13.017.
Xu L, Cai M, Li ZL, et al. A clinical analysis for low-dose intravenous infusion of human immunoglobulin in patients with positive panel reaction antibody for renal transplantation[J]. Chin J Mod Med, 2016, 26(13): 89-91. DOI: 10.3969/j.issn.1005-8982.2016.13.017.
|
| [17] |
Trivedi HL, Terasaki PI, Ferozetal A. Abrogation of Anti-HLA antibodies via proteasome inhibition[J]. Transplantation, 2009, 87(10): 1555-1561. DOI: 10.1097/TP.0b013e3181a4b91b.
|
Figures(4)
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad:
